Healthcare providers' knowledge, experience and challenges of reporting adverse events following immunisation: a qualitative study

被引:38
作者
Parrella, Adriana [1 ,2 ]
Braunack-Mayer, Annette [3 ]
Gold, Michael [1 ]
Marshall, Helen [1 ]
Baghurst, Peter [1 ]
机构
[1] Univ Adelaide, Sch Paediat & Reprod Hlth, Discipline Paediat, Adelaide, SA, Australia
[2] Univ Adelaide, Sch Populat Hlth, Discipline Publ Hlth, Adelaide, SA, Australia
[3] Univ Adelaide, Sch Populat Hlth, Adelaide, SA, Australia
基金
英国医学研究理事会;
关键词
Adverse event following immunisation (AEFI); Surveillance; Healthcare provider; Reporting; Qualitative; ASSESSING VACCINE SAFETY; DRUG-REACTIONS; SURVEILLANCE; BARRIERS; SYSTEM; ATTITUDES; CHILDREN; ROUTINE; MODEL;
D O I
10.1186/1472-6963-13-313
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Healthcare provider spontaneous reporting of suspected adverse events following immunisation (AEFI) is central to monitoring post-licensure vaccine safety, but little is known about how healthcare professionals recognise and report to surveillance systems. The aim of this study was explore the knowledge, experience and attitudes of medical and nursing professionals towards detecting and reporting AEFI. Methods: We conducted a qualitative study, using semi-structured, face to face interviews with 13 Paediatric Emergency Department consultants from a tertiary paediatric hospital, 10 General Practitioners, 2 local council immunisation and 4 General Practice nurses, recruited using purposive sampling in Adelaide, South Australia, between December 2010 and September 2011. We identified emergent themes related to previous experience of an AEFI in practice, awareness and experience of AEFI reporting, factors that would facilitate or impede reporting and previous training in vaccine safety. Thematic analysis was used to analyse the data. Results: AEFI reporting was infrequent across all groups, despite most participants having reviewed an AEFI. We found confusion about how to report an AEFI and variability, according to the provider group, as to the type of events that would constitute a reportable AEFI. Participants' interpretation of a "serious" or "unexpected" AEFI varied across the three groups. Common barriers to reporting included time constraints and unsatisfactory reporting processes. Nurses were more likely to have received formal training in vaccine safety and reporting than medical practitioners. Conclusions: This study provides an overview of experience and beliefs of three healthcare professional groups in relation to identifying and reporting AEFI. The qualitative assessment reveals differences in experience and awareness of AEFI reporting across the three professional groups. Most participants appreciated the importance of their role in AEFI surveillance and monitoring the ongoing safety of vaccines. Future initiatives to improve education, such as increased training to health care providers, particularly, medical professionals, are required and should be included in both undergraduate curricula and ongoing, professional development.
引用
收藏
页数:12
相关论文
共 40 条
[11]  
Duclos P, 1997, CAN FAM PHYSICIAN, V43, P1551
[12]   Pharmacy Students' Knowledge and Perceptions About Pharmacovigilance in Malaysian Public Universities [J].
Elkalmi, Ramadan Mohamed ;
Hassali, Mohamed Azmi ;
Ibrahim, Mohamed Izham M. ;
Widodo, Riyanto T. ;
Efan, Qais M. A. ;
Hadi, Muhammad Abdul .
AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION, 2011, 75 (05)
[13]   Attitudes and barriers to incident reporting: a collaborative hospital study [J].
Evans, SM ;
Berry, JG ;
Smith, BJ ;
Esterman, A ;
Selim, P ;
O'Shaughnessy, J ;
DeWit, M .
QUALITY & SAFETY IN HEALTH CARE, 2006, 15 (01) :39-43
[14]   The lack of knowledge about the voluntary reporting system of adverse drug reactions as a major cause of underreporting: direct survey among health professionals [J].
Garcia, Mariley Perez ;
Figueras, Albert .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 (12) :1295-1302
[15]  
Gidudu J, 2012, VACCINE, V30, P5590, DOI 10.1016/j.vaccine.2011.03.078
[16]   Use of the Australian Childhood Immunisation Register for vaccine safety data linkage [J].
Gold, Michael ;
Dugdale, Sarah ;
Woodman, Richard J. ;
McCaul, Kieran A. .
VACCINE, 2010, 28 (26) :4308-4311
[17]   Physician response to patient reports of adverse drug effects - Implications for patient-targeted adverse effect surveillance [J].
Golomb, Beatrice A. ;
McGraw, John J. ;
Evans, Marcella A. ;
Dimsdale, Joel E. .
DRUG SAFETY, 2007, 30 (08) :669-675
[18]   What Should an Ideal Vaccine Postlicensure Safety System Be? [J].
Griffin, Marie R. ;
Braun, M. Miles ;
Bart, Kenneth J. .
AMERICAN JOURNAL OF PUBLIC HEALTH, 2009, 99 :S345-S350
[19]   A Survey on the Knowledge, Attitude and the Practice of Pharmacovigilance Among the Health Care Professionals in a Teaching Hospital in Northern India [J].
Hardeep ;
Bajaj, Jagminder Kaur ;
Kumar, Rakesh .
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2013, 7 (01) :97-99
[20]   Under-reporting of adverse drug reactions - A systematic review [J].
Hazell, Lorna ;
Shakir, Saad A. W. .
DRUG SAFETY, 2006, 29 (05) :385-396